Abuse Potential of Hydrocodone in Human Studies
|
|
- Mae Wilkinson
- 8 years ago
- Views:
Transcription
1 Abuse Potential of Hydrocodone in Human Studies Sharon L. Walsh, Ph.D. Center on Drug and Alcohol Research University of Kentucky Report to the Drug Safety and Risk Management Advisory Committee January 24-25, 13
2 Outline Abuse potential vs. abuse liability Human laboratory approach Populations and methods Results from published studies Normal volunteers Opioid abusers Summary of results 2
3 Abuse Potential vs. Abuse Liability Abuse Potential Characterizes the ability of a CNS-active drug to produce positive psychoactive effects may include sedation, euphoria, perceptual and other cognitive distortions, hallucinations and mood changes. These effects are viewed as correlated with or predictive of the risk of abuse and/or addiction 3
4 Abuse Potential vs. Abuse Liability Abuse Liability Is similar and sometimes used interchangeably Includes abuse potential Captures other factors, including ease of synthesis and drug abuse/diversion history Describes abuse potential in a social and public health context 4
5 How Are They Measured? 5
6 Human Abuse Potential Studies: General Methods Enroll adult volunteers with appropriate drug use histories (preferably as inpatients) opioid abuse histories (but without physical dependence) Include tests of the appropriate control (positive and negative if available) agents for comparison with the test drug of interest Control condition(s) full mu opioid agonist Double-blind testing is employed 6
7 Human Abuse Potential Studies: General Methods Collect a comprehensive array of outcomes Physiological Respiratory, cardiovascular, pupil diameter Subjective measures Visual analog questionnaires Adjective scales Street value estimates Observer-rated effects Cognitive/psychomotor tasks Assess impairment 7
8 Contemporary Studies of Hydrocodone Available for Review Six human abuse potential studies of hydrocodone [published between 3 to ] Five of oral hydrocodone Hydrocodone/homatropine (Hycodan ) (n=1) Hydrocodone/acetaminophen (n=3) Hydrocodone alone (n=1) One of intravenous hydrocodone alone All studies employed within-subject, crossover designs Conducted in healthy non-drug-abusing volunteers 8
9 Hydrocodone/Homatropine: Hycodan Healthy Volunteers Pupil Diameter How Much Do You LIKE the Drug? 6.5 Trough Diameter (mm) Mean Peak Score Positive Negative 5 (1.5) (3) (6) Hydrocodone (Homatropine, mg) 4 2 Morphine Lorazepam 5 (1.5) (3) (6) Hydrocodone (Homatropine, mg) 4 2 Morphine Lorazepam Zacny J.P. (3) Psychopharmacology, 165:
10 Hydrocodone/Acetaminophen Healthy Volunteers Pupil Diameter How Much Do You LIKE the Drug? 6.5 Trough Diameter (mm) Mean Peak Score Positive Negative 5 (5) (5) () Hydrocodone (Acetaminophen, mg) 4 Morphine Acetaminophen 5 (5) (5) () Hydrocodone (Acetaminophen, mg) 4 Morphine Acetaminophen Zacny, Gutierrez & Bolbolan (5) Drug and Alcohol Dependence: 78:
11 Hydrocodone/ACET & Oxycodone/ACET Healthy Volunteers 6.5 Pupil Diameter How Much Do You LIKE the Drug? 7 Trough Pupil Size (mm) Mean Peak Score (487) (975) 15 (487) 3 (975) (487) (975) 15 (487) 3 (975) Oxycodone (Acetaminophen, mg) Hydrocodone (Acetaminophen, mg) Oxycodone (Acetaminophen, mg) Hydrocodone (Acetaminophen, mg) Zacny & Gutierrez (9) Drug and Alcohol Dependence, 1:
12 Hydrocodone/ACET & Oxycodone/ACET Healthy Volunteers Coasting Nauseated 5 4 Mean Peak Score 4 3 Mean Peak Score 3 (487) (975) 15 (487) 3 (975) (487) (975) 15 (487) 3 (975) Oxycodone (Acetaminophen, mg) Hydrocodone (Acetaminophen, mg) Oxycodone (Acetaminophen, mg) Hydrocodone (Acetaminophen, mg) Zacny & Gutierrez (9) Drug and Alcohol Dependence, 1:
13 Oxycodone, Hydrocodone & Hydromorphone Prescription Opioid Abusers How Much Do You LIKE the Drug? Oxycodone Hydrocodone Hydromorphone Visual Analog Scale (mm) mg mg mg 4 mg BL mg 15 mg 3 mg 45 mg mg mg 17.5 mg 25 mg 6 BL BL Time (hour) Time (hour) Time (hour) Walsh, Nuzzo, Lofwall & Holtman (8) Drug and Alcohol Dependence, 98:
14 Oxycodone, Hydrocodone & Hydromorphone Prescription Opioid Abusers Pupil Diameter Respiratory Rate Placebo Oxycodone 14 Diameter (mm) Hydromorphone Hydrocodone Breaths/minute Dose Dose Walsh, Nuzzo, Lofwall & Holtman (8) Drug and Alcohol Dependence, 98:
15 Oxycodone, Hydrocodone & Hydromorphone Prescription Opioid Abusers Agonist Scale - Subject Agonist Scale - Observer Score 15 Score Placebo Oxycodone Hydromorphone Hydrocodone Dose Dose Walsh, Nuzzo, Lofwall & Holtman (8) Drug and Alcohol Dependence, 98:
16 Relative Potency Estimates Only variables meeting the criteria for a valid bioassay were included (Finney, 1964) Mean relative potency estimates across outcomes Oxycodone : Hydrocodone =.93 mg : 1 mg Finney D.J. (1964) Statistical Method in Biological Assay, 2 nd Ed. Hafner, NY. 16
17 Intravenous Morphine, Oxycodone & Hydrocodone Prescription Opioid Abusers How Much Do You LIKE the Drug? Morphine Oxycodone Hydrocodone 6 Visual Analog Scale (mm) mg 5 mg mg mg mg 5 mg mg mg mg 5 mg mg mg BL BL BL Time (min) Time (min) Time (min) Stoops, Hatton, Lofwall, Nuzzo & Walsh () Psychopharmacology, 212:
18 Intravenous Morphine, Oxycodone & Hydrocodone Prescription Opioid Abusers Pupil Diameter Expired End-Tidal CO 2 Trough Diameter (mm) mmhg Morphine (mg, i.v.) Oxycodone (mg, i.v.) Hydrocodone (mg, i.v.) Morphine (mg, i.v.) Oxycodone (mg, i.v.) Hydrocodone (mg, i.v.) Stoops, Hatton, Lofwall, Nuzzo & Walsh () Psychopharmacology, 212:
19 Intravenous Morphine, Oxycodone & Hydrocodone Prescription Opioid Abusers 5 Street Value U.S. Dollars Morphine (mg, i.v.) Oxycodone (mg, i.v.) Hydrocodone (mg, i.v.) Stoops, Hatton, Lofwall, Nuzzo & Walsh () Psychopharmacology, 212:
20 Summary: Studies in Healthy Volunteers Hydrocodone (in combination with homatropine or acetaminophen) produces dose dependent euphorigenic effects These effects are similar to those of morphine and oxycodone Hydrocodone mg ~ Morphine 4 mg Hydrocodone 3 mg ~ Oxycodone mg ACET produces no discernible effects alone Unpleasant effects (e.g., nausea, dizziness) occurred at the upper end of the hydrocodone dose range (as with other opioids)
21 Summary: Studies in Prescription Opioid Abusers Hydrocodone produces dose dependent increases on ratings of positive subjective reports, including ratings of liking, good effects and endorsements of street value There is little to no evidence that hydrocodone produces reports of negative or unpleasant symptoms Hydrocodone is only slightly less potent than oxycodone on subjective effects related to abuse potential The profile of hydrocodone is similar to comparator opioids, including morphine, hydromorphone and oxycodone 21
A HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES. Donald R Jasinski, MD
A HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES Donald R Jasinski, MD Origin of methods Modify morphine molecule Develop a selective analgesic lacking abuse potential Reduce public health and
More informationPrescription Opioid Abuse: Translating Laboratory Findings to Clinical Practice
Prescription Opioid Abuse: Translating Laboratory Findings to Clinical Practice Sharon L. Walsh, Ph.D. Center on Drug and Alcohol Research University of Kentucky Association for Medical Education and Research
More information2.0 Synopsis. Vicodin CR (ABT-712) M05-765 Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:
2.0 Synopsis Abbott Laboratories Name of Study Drug: Vicodin CR Name of Active Ingredient: Hydrocodone/Acetaminophen Extended Release (ABT-712) Individual Study Table Referring to Part of Dossier: Volume:
More informationOctober 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,
October 2012 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.
More informationUltram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.35 Subject: Tramadol Acetaminophen Page: 1 of 8 Last Review Date: September 18, 2015 Tramadol Acetaminophen
More informationPOST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
More informationUse of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which
More informationopiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
More informationThe TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program
Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential
More informationHarnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data
Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data William C. Becker, MD Assistant Professor, General Internal Medicine VA Connecticut
More informationAmphetamines Addiction
Introduction Amphetamines, which are classified as stimulants, work by using the dopamine reward system of the brain. When these drugs are used, the user s central nervous system is simulated which causes
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationA Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation
A Healthesystems Clinical Analysis Insidious Incrementalism of Opioid Use in Workers Compensation Prescription opioid use in the United States has grown significantly over the past 20 years. In 1991, there
More informationTITLE: Abuse and Misuse Potential of Pregabalin: A Review of the Clinical Evidence
TITLE: Abuse and Misuse Potential of Pregabalin: A Review of the Clinical Evidence DATE: 24 April 2012 CONTEXT AND POLICY ISSUES Pregabalin (Lyrica) is an anticonvulsant approved in Canada and the United
More informationPROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain
P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract
More informationWe re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones
We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones Learn about the history of opioid addiction and discuss what is happening today in Kentucky Learn about the disease of
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationOpiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern
More informationA dose effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers
Drug and Alcohol Dependence 74 (2004) 205 209 Short communication A dose effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers Miriam Z. Mintzer
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationWeaning off your pain medicine
Weaning off your pain medicine UHN Information for patients taking opioid pain medicines Read this booklet to learn about: why you need to wean off your pain medicine how to wean off slowly how to control
More informationPARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering
More informationNaloxone treatment of opioid overdose
Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing
More informationDEPARTMENT OF PSYCHIATRY. 1153 Centre Street Boston, MA 02130
DEPARTMENT OF PSYCHIATRY 1153 Centre Street Boston, MA 02130 Who We Are Brigham and Women s Faulkner Hospital (BWFH) Department of Psychiatry is the largest clinical psychiatry site in the Brigham / Faulkner
More informationUNIT VIII NARCOTIC ANALGESIA
UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and
More informationMedical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
More informationOPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School
OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013
More informationNaltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
More informationDrug and Alcohol Abuse Training revised: October 2015
Drug and Alcohol Abuse Training revised: October 2015 FMCSA is considering going to a seven panel and possibly ten panel. Hair testing may also be acceptable. What is a Drug? A substance which
More informationTHE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine
THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine Volume 1, Issue 1 August 2007 The Depression Research Clinic at Stanford University
More informationBrian Johnson M.D. Associate Professor Psychiatry/Anesthesia SUNY Upstate Member Boston Psychoanalytic Society
Brian Johnson M.D. Associate Professor Psychiatry/Anesthesia SUNY Upstate Member Boston Psychoanalytic Society Receptors: Mu, Delta, Kappa, Nociceptin Mu agonist goal of use Routes of administration Eating
More informationSTATISTICS. Opiate Substitution Therapy for Opiate Dependence. Alan Shein, M.D.
Opiate Substitution Therapy for Opiate Dependence Alan Shein, M.D. OH #1-1 STATISTICS Prevalence of Specific Drug Abuse and Vulnerability to Develop Addictions National Household Survey and Related Surveys
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationACUTE EFFECTS OF LORATADINE, DIPHENHYDRAMINE AND PLACEBO, ALONE AND WITH ALCOHOL, ON SKILLS PERFORMANCE
ACUTE EFFECTS OF LORATADINE, DIPHENHYDRAMINE AND PLACEBO, ALONE AND WITH ALCOHOL, ON SKILLS PERFORMANCE C. Jeavons Wilkinson and Herbert Moskowitz University of California at Los Angeles (UCLA) and Southern
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationAcute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel
More informationThe CCB Science 2 Service Distance Learning Program
S2S 2055 DETOXIFICATION Module 1 Post-Test 1. A common use of a biochemical marker is. a. to support or refute other information that leads to proper diagnosis b. for forensic purposes c. in detecting
More informationHow to take your Opioid Pain Medication
How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,
More informationAlcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma
Alcohol & Chemical Dependence Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma Objectives Increased awareness of alcohol and chemical dependence problems Hallmarks of
More informationFederal and State Laws Relating to Prescribing of Controlled Substances
Federal and State Laws Relating to Prescribing of Controlled Substances Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationHow To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationA Report on Marijuana and Prescription Drugs
Prescription Drug Misuse in America A Report on Marijuana and Prescription Drugs Table of Contents Summary 2 Prescription Drug Misuse is Prevalent 6 Marijuana: The Most Misused Drug 8 Recreational Marijuana
More informationYoung Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer
More informationClinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More informationSAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
More informationMedications for chronic pain
Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may
More informationGenera&on O How did we get here? What can we do?
Genera&on O How did we get here? What can we do? Melanie Willows B.Sc. M.D. C.C.F.P. C.A.S.A.M. C.C.S.A.M. Clinical Director, Substance Use and Concurrent Disorders Program Mano&ck Public Informa&on Mee&ng
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationP3 / PERSONAL ASPECTS. Drugs
P1 / DRUGS An addiction treatment facility such as Delray Recovery Center often treats patients who are addicted to more than one drug. P2 / SUBSTANCES Learn about Alcohol and Amphetamines, including the
More informationAlcohol Overuse and Abuse
Alcohol Overuse and Abuse ACLI Medical Section CME Meeting February 23, 2015 Daniel Z. Lieberman, MD Professor and Vice Chair Department of Psychiatry George Washington University Alcohol OVERVIEW Definitions
More informationPrescription Opioid Analgesic Dependence and Addiction: Experience in the United States
Prescription Opioid Analgesic Dependence and Addiction: Experience in the United States October 10, 2013 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center Professor, University of
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationThe Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
More informationTriage, Assessment & Treatment
Triage, Assessment & Treatment Launette Rieb, MSc, MD, CCFP, FCFP, dip ABAM Clinical Associate Professor, Dept. Family Practice, UBC Physician Director, St. Paul's Hospital Goldcorp Addiction Medicine
More informationGeneral PROVIDER INITIALS: PHYSICIAN ORDERS
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
More informationPrescription Drug Monitoring Programs: Evaluation of Effectiveness
Prescription Drug Monitoring Programs: Evaluation of Effectiveness Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Denver Health and Hospital Authority Associate Professor, Department
More informationBACHELOR OF SCIENCE IN NURSING STUDENT HANDBOOK 45
BACHELOR OF SCIENCE IN NURSING STUDENT HANDBOOK 45 Drug Testing Policy Background: The Muskingum University Department of Nursing (DON) drug testing policy was established to meet contractual requirements
More informationDowners/Depressants (pages 40-50)
Downers/Depressants (pages 40-50) Read pages 49-54, 59-60, and 78-79 of the booklet, Street Drugs. Pages 40-50 of the text. Narcotics: Prescription Origin: Southeast Asia, Southwest Asia, and in the Western
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationHow To Get A Tirf
Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under This Program Abstral (fentanyl)
More informationOpioid Analgesics. Week 19
Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,
More information10/28/2014. Collecting the Raw Opium
Opioid Analgesics (or Narcotic Analgesics) We are moving on to a new category of drugs whose effects, superficially, may look similar to those of the CNS depressants, but the drugs are, in fact, a completely
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationPain Therapeutics, Inc.
Pain Therapeutics, Inc. Pioneers in Preventing Prescription Drug Abuse Remi Barbier President & CEO June 2014 1 Forward-Looking Statements This presentation contains forward-looking statements within the
More informationImplementing Prescribing Guidelines in the Emergency Department. April 16, 2013
Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationSELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationThe Adverse Health Effects of Cannabis
The Adverse Health Effects of Cannabis Wayne Hall National Addiction Centre Kings College London and Centre for Youth Substance Abuse Research University of Queensland Assessing the Effects of Cannabis
More informationAcute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS
Update in Anaesthesia Acute pain management for opioid tolerant patients Simon Marshall and Mark Jackson* *Correspondence email: mark.jackson@rdeft.nhs.uk INTRODUCTION Opioid tolerance is usually encountered
More informationHow To Treat An Alcoholic Patient
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationCollege of Education. Rehabilitation Counseling
* 515 MEDICAL AND PSYCHOSOCIAL ASPECTS OF DISABILITIES I. (3) This course is designed to prepare rehabilitation and mental health counselors, social works and students in related fields with a working
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More informationThis module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions
More informationNurses Self Paced Learning Module on Pain Management
Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationDrug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 2014
Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 24 Alice A. Gleghorn, Ph.D. ABSTRACT In San Francisco, increases in heroin consequence indicators (treatment admissions and Drug
More informationMEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model
MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT An Outpatient Model OBJECTIVE TO PRESENT A PROTOCOL FOR THE EVALUATION AND TREATMENT OF PATIENTS WHO ARE CHEMICALLY DEPENDENT ON OR SEVERLY
More informationAddiction, OCD, & riding a bike: how opiates control your brain
Addiction, OCD, & riding a bike: how opiates control your brain Shay Neufeld PhD candidate, neuroscience April 22nd, 2015 1. What are opiates? what you are in for 2. Where is opiate addiction in the brain?
More information1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationSymptom Based Alcohol Withdrawal Treatment
Symptom Based Alcohol Withdrawal Treatment -Small Rural Hospital- Presenter CDR Dwight Humpherys, DO dwight.humpherys@ihs.gov Idaho State University Baccalaureate Nursing Program Lake Erie College of Osteopathic
More informationA Position Statement from the American Academy of Pain Medicine
FOR IMMEDIATE RELEASE Contact Information Email: info@painmed.org Attn: Director of Communications American Academy of Pain Medicine Phone: 847-375-4731 A Position Statement from the American Academy of
More informationNew Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**
New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** Disclaimer This presentation was created to assist in the education of EMTs in Naloxone administration.
More informationA Phase 2 Study of HTX-011 in the Management of Post-Operative Pain Positive Top-Line Results
A Phase 2 Study of HTX-011 in the Management of Post-Operative Pain Positive Top-Line Results September 22, 2015 Forward-Looking Statements This presentation contains "forward-looking statements" as defined
More informationUnderstanding Your Pain
Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.
More informationOpioid Dependence. Average Purity of Retail Heroin Street Samples in U.S
Opioid Dependence Andrew J. Saxon, M.D. University of Washington, Seattle VA Puget Sound Health Care System Average Purity of Retail Heroin Street Samples in U.S 4 35 3 25 2 15 1 5 198's 1991 2 Source:
More informationGUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE
GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE Dr Millicent Chikoore MBBS MRCPsych Dr O Lagundoye MBBS MRCPsych Community based alcohol detoxification is a safe and effective option for
More informationTrends of Opioid Misuse and Diversion: Lessons from the United States
Trends of Opioid Misuse and Diversion: Lessons from the United States 31 October 2012 Richard C. Dart, MD, PhD Director Rocky Mountain Poison and Drug Center Professor - University of Colorado, Department
More informationOPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow
OPIOID NEUROTOXICITY - BACK TO BASICS Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OBJECTIVES Some Cases Definitions: Including what is opioid neurotoxicity A bit of biochemistry What patients
More informationAlcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
More informationJennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
More informationSouthlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
More information